Advanced Parenteral Drug Market, Revenue Growth, Key Factors, Major Companies, Forecast To 2032
The global advanced parenteral drug market size was valued at USD 2.64 billion in 2022 and is expected to reach a value of USD 4.6 billion in 2032 and register a revenue CAGR of 7.2% during the forecast period. The market growth is primarily driven by the increasing prevalence of chronic diseases such as cancer, Diabetes, and autoimmune diseases. Advanced parenteral drugs are used for the treatment of these diseases as they provide rapid onset of action, targeted therapy, and improved patient outcomes.
